Results 231 to 240 of about 448,489 (363)

Vitamin‐Engineered Nanoplatforms in Precision Oncology: Integrating Immunotherapy, Delivery Systems, and Theranostics

open access: yesMedComm – Biomaterials and Applications, Volume 4, Issue 4, December 2025.
Vitamin‐derived nanoplatforms advance precision oncology by augmenting immunotherapy through dendritic cell activation, T‐cell reprogramming, and TME remodeling to enhance antitumor immunity, while enabling targeted therapeutic delivery. These systems integrate theranostic capabilities using vitamin‐conjugated imaging probes for concurrent tumor ...
Ruowa Xu   +3 more
wiley   +1 more source

Evaluating the effect of crocin on contrast-induced nephropathy in rats. [PDF]

open access: yesAvicenna J Phytomed
Zolfaghari Farajerdi M   +6 more
europepmc   +1 more source

Aryl Hydrocarbon Receptor in Health and Disease

open access: yesMedComm, Volume 6, Issue 11, November 2025.
Based on the structure and ligands of AhR, this review introduces the AhR‐related signaling pathways and their roles in health and diseases. Agonists and antagonists of AhR as well as new strategies for treatment using the microbial–AhR axis are summarized. A prospect was made for the future use of AhR as a therapeutic target.
Haonan Li   +11 more
wiley   +1 more source

Efficacy of N-acetylcysteine and aminophylline in preventing contrast-induced nephropathy

open access: bronze, 2009
Terufumi Kinbara   +5 more
openalex   +1 more source

Impact of Blood Pressure Across the Life Course on Arterial Stiffness in Midlife: The Mediating Role of Metabolic Factors

open access: yesMedComm, Volume 6, Issue 11, November 2025.
This 30‐year cohort study demonstrates that elevated blood pressure (BP) since childhood contributes to arterial stiffness in midlife, with adult BP showing the strongest association. The triglyceride–glucose index partially mediates this relationship, especially in males. These findings highlight the importance of early BP control and metabolic health
Yang Wang   +25 more
wiley   +1 more source

Home - About - Disclaimer - Privacy